Aliabadi Nasrin, Jamaliduost Marzieh, Pouladfar Gholamreza, Marandi Nahid H, Ziyaeyan Mazyar
Department of Clinical Virology, Clinical Microbiology Research Center, Shiraz University of Medical Sciences Namazi Hospital Shiraz Iran.
Health Sci Rep. 2023 Jan 16;6(1):e1052. doi: 10.1002/hsr2.1052. eCollection 2023 Jan.
Characterization of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) based on analyzing the evolution and mutations of viruses is crucial for tracking viral infections, potential mutants, and other pathogens. The purpose was to study the complete sequences of SARS-CoV-2 to reveal genetic distance and mutation rate among different provinces of Iran.
As of March 2020-April 2021, a total of 131 SARS-CoV-2 whole genome sequences submitted from Tehran and 133 SARS-CoV-2 full-length sequences from 24 cities with high coverage submitted to EpiCoV GISAID database were analyzed to infer clades and mutation annotation compared with the wild-type variant Wuhan-Hu-1.
The results of variant annotation were revealed 11,204 and 9468 distinct genomes were identified among the samples from different cities and Tehran, respectively. The phylogenetic analysis of genomic sequences showed the presence of eight GISAID clades, namely GH, GR, O, GRY, G, GK, L, and GV, and six Nextstrain clades; that is, 19A, 20A, 20B, 20I (alpha, V1), 20H (Beta, V2), and 21I (Delta) in Iran. The GH (GISAID clade), 20A (Nextstrain clade), and B.1 (Pango lineage) were predominant in Iran. Notably, analysis of the spike protein revealed D614G mutation (S_D614G) in 56% of the sequences. Also, the delta variant of the coronavirus, the super-infectious strain that was first identified among the sequences submitted from the southern cities of the country such as Zahedan, Yazd and Bushehr, and most likely from these places to other cities of Iran as well has expanded.
Our results indicate that most of the circulated viruses in Iran in the early time of the pandemic had collected in eight GISAID clades. Therefore, a continuous and extensive genome sequence analysis would be necessary to understand the genomic epidemiology of SARS-CoV-2 in Iran.
基于分析病毒的进化和突变来鉴定严重急性呼吸综合征冠状病毒2(SARS-CoV-2),对于追踪病毒感染、潜在突变体及其他病原体至关重要。目的是研究SARS-CoV-2的完整序列,以揭示伊朗不同省份之间的遗传距离和突变率。
截至2020年3月至2021年4月,对从德黑兰提交的131条SARS-CoV-2全基因组序列以及提交至EpiCoV GISAID数据库的来自24个高覆盖城市的133条SARS-CoV-2全长序列进行分析,以推断进化枝并与野生型毒株武汉-胡-1进行突变注释比较。
变异注释结果显示,在来自不同城市和德黑兰的样本中分别鉴定出11204个和9468个不同的基因组。基因组序列的系统发育分析显示存在8个GISAID进化枝,即GH、GR、O、GRY、G、GK、L和GV,以及6个Nextstrain进化枝;也就是说,在伊朗存在19A、20A、20B、20I(α,V1)、20H(β,V2)和21I(δ)。GH(GISAID进化枝)、20A(Nextstrain进化枝)和B.1(Pango谱系)在伊朗占主导地位。值得注意的是,对刺突蛋白的分析显示56%的序列存在D614G突变(S_D614G)。此外,冠状病毒的δ变异株,这种超级传染性毒株最早在该国南部城市如扎黑丹、亚兹德和布什尔提交的序列中被发现,并且很可能从这些地方传播到伊朗的其他城市,其传播范围也在扩大。
我们的结果表明,在疫情早期,伊朗大多数传播的病毒聚集在8个GISAID进化枝中。因此,有必要进行持续广泛的基因组序列分析,以了解伊朗SARS-CoV-2的基因组流行病学情况。